|
|
Article: FDA APPROVES TRACLEER PULMONARY HYPERTENSION DRUG.
- Article from:
- Biotech Business
- Article date:
- February 1, 2002
CopyrightCOPYRIGHT 2002 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Tracleer, the first pill for treatment of pulmonary hypertension, has been approved by the U.S. Food and Drug Administration.
Tracleer (bosentan) acts against a hormone called endothelin causing constriction of blood vessels and elevating blood pressure. Studies demonstrate that Tracleer is "extremely powerful" in improving heart function and reducing shortness of breath in patients with pulmonary hypertension.
Pulmonary hypertension is a serious condition of the lungs and heart for which no cure exists. The condition is usually very rare but new reports suggest the popular diet drug combination popularly known as fen-phen -- used by an estimated six ...